double-blind multicenter trial treatment frequency urgency incontinence hyperactivity oxybutynin versus propantheline versus placebo Clinical efficacy adverse effects oxybutynin propantheline treatment symptoms hyperactivity randomized double-blind multicenter trial patients study evaluable statistical analysis Mean grade improvement visual analogue scale oxybutynin versus propantheline placebo Mean bladder volume first involuntary cystometric contraction oxybutynin ml versus placebo Mean maximum cystometric bladder capacity oxybutynin ml versus placebo Rate possible adverse effects oxybutynin versus propantheline placebo patients study adverse effects oxybutynin serious lasting adverse effects dryness mouth major complaint Oxybutynin significant effects subjective symptoms objective urodynamic parameters patients detrusor hyperactivity 